June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Establishing the need for regular surveillance of ocular pathologies in patients with Down's Syndrome
Author Affiliations & Notes
  • Noor Ghali
    Ophthalmology, University Hospitals, Cleveland, Ohio, United States
  • Andy Kuo
    Ophthalmology, University Hospitals, Cleveland, Ohio, United States
  • Zeina Salem
    Ophthalmology, University Hospitals, Cleveland, Ohio, United States
  • Faruk Orge
    Ophthalmology, University Hospitals, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Noor Ghali None; Andy Kuo None; Zeina Salem None; Faruk Orge Regeneron , Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3061. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Noor Ghali, Andy Kuo, Zeina Salem, Faruk Orge; Establishing the need for regular surveillance of ocular pathologies in patients with Down's Syndrome. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3061.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although the association of Down's Syndrome (DS) with ocular pathologies has been long-established, ophthalmic eye exams have yet to be implemented as part of the required health maintenance routine in DS patients. We are performing a retrospective, observational clinical study on patients with Down's Syndrome to investigate the frequency of ocular findings in this patient population.

Methods : This study includes a retrospective review of electronic medical record data from the University Hospitals database over a 14-year time period (January 2008 - October 2022). A total of 1,445 patient records of individuals age 1 month - 69 years with a known Down's Syndrome diagnosis are available for analysis. Thus far, 334 patient records were analyzed. Of these patients, only 76 have an ophthalmic eye exam on record. The medical records of these patients were further evaluated for the presence of an ocular diagnosis. Data collection is still underway and will include the mean age and standard deviation of our patient population. Statistical analyses will be conducted using SPSS software, T-Test and Chi-square to measure the average degree of refractive error in DS patients compared to a control population of patients without Down's Syndrome that had an ophthalmic eye exam performed within the respective time frame.

Results : Out of 334 patient records analyzed, only 76 (22.75%) patients had an ophthalmic eye exam on file. Out of the 76 patient charts analyzed, 48 (63.16%) suffered from astigmatism, 43 (56.58%) suffered from hypermetropia and 15 (19.75%) suffered from myopia. 5 individuals (6.58%) suffered from anisometropia and 6 (7.89%) suffered from congenital nystagmus. Of the individuals that suffered from strabismus, 22 (28.95%) had esotropia and 4 (5.26%) had exotropia. 13 (17.11%) patients had a congenital nasolacrimal duct obstruction. 4 (5.26%) suffered from congenital cataracts and 5 (6.58%) suffered from age-related cataracts. Finally, 3 (3.95%) of our patients suffered from keratoconus.

Conclusions : The overwhelming majority of Down’s Syndrome patients do not undergo regular ophthalmic eye exams despite the high association of this disorder with ocular pathologies. It is possible that many DS patients have undiagnosed ocular pathologies that are left undetected. Our results emphasize the importance of routine eye exams in the health maintenance regimen of patients with Down’s Syndrome.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×